Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2016.
Aytu BioScience Inc. granted various partners licenses to commercialize its MiOXSYS semen analysis system in Europe, where it obtained the CE mark in January 2016. (Jun.)
The MiOXSYS is Aytu's in vitro diagnostic platform for assessing the level of oxidative stress in semen to diagnose infertility....